$30.22 -0.24 (%) Pfizer Inc - NYSE

Nov. 24, 2014 | 12:30 PM

Partner Headlines

  1. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  2. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  3. Vipshop Leads 4 Top Stocks With Bolting RS Lines

    IBD | Nov. 18, 2014 | 08:02AM EST
  4. U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts

    Benzinga | Nov. 17, 2014 | 16:46PM EST
  5. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  6. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  7. #PreMarket Primer: Monday, November 17: Japan's Economy Unexpectedly Slips

    Benzinga | Nov. 17, 2014 | 08:33AM EST
  8. Pfizer Shares Trending Lower Following Lowered FY2014 EPS Guidance

    Benzinga | Nov. 17, 2014 | 08:08AM EST
  9. Guru Ken Fisher's Top Five Quarterly Stocks

    GuruFocus | Nov. 16, 2014 | 23:17PM EST
  10. Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca

    Benzinga | Nov. 14, 2014 | 09:38AM EST
  11. Ackman's Pershing Group Buys Stake in Zoetis

    GuruFocus | Nov. 13, 2014 | 11:23AM EST
  12. Ackman's Pershing Square Buys Stake in Zoetis

    GuruFocus | Nov. 13, 2014 | 11:23AM EST
  13. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus | Nov. 12, 2014 | 15:29PM EST
  14. Activist Bill Ackman Buys Big Stake In Animal Healthcare Company Zoetis

    GuruFocus | Nov. 12, 2014 | 12:37PM EST
  15. Why Pfizer Is At A Technical 'Fork In The Road'

    Benzinga | Nov. 11, 2014 | 10:26AM EST
  16. Energy Stocks: Cash Metric Flashes “Oversold”

    YCharts | Nov. 11, 2014 | 03:43AM EST
  17. Will Pfizer Sweeten Its Bid For AstraZeneca?

    IBD | Nov. 6, 2014 | 18:41PM EST
  18. Divided Government Won't Halt Wall Street's Run

    FoxBusiness | Nov. 6, 2014 | 09:58AM EST
  19. Monotype Gets Its Font Tech Deeper Into Advertising

    IBD | Nov. 5, 2014 | 18:26PM EST
  20. Minerals Technologies Digs Up A Winner With Buyout

    IBD | Nov. 3, 2014 | 13:47PM EST
  21. The Importance of Capital Intensity and Thoughts From Einhorn

    GuruFocus | Oct. 31, 2014 | 11:35AM EST
  22. Johnson & Johnson Fairly Valued - I Will Bet on It

    GuruFocus | Oct. 30, 2014 | 12:26PM EST
  23. Buybacks-Driven Market: Engineered Too Far?

    YCharts | Oct. 29, 2014 | 12:36PM EST
  24. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond Purchases

    Benzinga | Oct. 29, 2014 | 07:50AM EST
  25. Pfizer Q3 beats views

    IBD | Oct. 28, 2014 | 18:46PM EST
  26. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  27. Fast Money Traders Take Position On Stocks Making Headlines

    Benzinga | Oct. 28, 2014 | 15:59PM EST
  28. Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

    Benzinga | Oct. 28, 2014 | 15:39PM EST
  29. Pfizer Conference Call Highlights

    Benzinga | Oct. 28, 2014 | 15:36PM EST
  30. Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline

    Benzinga | Oct. 28, 2014 | 13:50PM EST
  31. Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View

    Benzinga | Oct. 28, 2014 | 11:06AM EST
  32. UPDATE: Pfizer Posts Stronger-Than-Expected Q3 Earnings

    Benzinga | Oct. 28, 2014 | 08:09AM EST
  33. 10 Stocks You Should Be Watching Today

    Benzinga | Oct. 28, 2014 | 04:16AM EST
  34. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  35. My 5 Favorite Stocks With Dividend Growth Of The Week

    GuruFocus | Oct. 27, 2014 | 12:09PM EST
  36. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 27, 2014 | 10:33AM EST
  37. Morning Market Losers

    Benzinga | Oct. 27, 2014 | 10:07AM EST
  38. Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More

    Benzinga | Oct. 26, 2014 | 16:55PM EST
  39. Markets End Hectic Week On Positive Note

    Benzinga | Oct. 24, 2014 | 17:16PM EST
  40. Pfizer Announces Share Buyback, Shares Pop Up

    Benzinga | Oct. 24, 2014 | 13:44PM EST
  41. Stocks Cling To Decent Gains; Alibaba Nears High

    IBD | Oct. 24, 2014 | 13:25PM EST
  42. PFIZER's

    IBD | Oct. 23, 2014 | 18:56PM EST
  43. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  44. Can Valeant's Strong Q3 Entice Allergan?

    IBD | Oct. 20, 2014 | 18:47PM EST
  45. Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU

    GuruFocus | Oct. 20, 2014 | 12:03PM EST
  46. UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda

    Benzinga | Oct. 17, 2014 | 16:27PM EST
  47. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD | Oct. 16, 2014 | 15:07PM EST
  48. Shire Can Thrive Without AbbVie, Say Analysts

    IBD | Oct. 16, 2014 | 11:19AM EST
  49. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  50. Fast Money Halftime Report Final Trade From October 13

    Benzinga | Oct. 13, 2014 | 16:17PM EST
Trading Center